| Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders |
Basic and diluted net loss per share attributable to common stockholders are calculated as follows (in thousands, except share and per share amounts): | | | | | | | | | | | | | Three Months Ended March 31, | | 2026 | | 2025 | | Net loss | $ | (1,028,344) | | | $ | (366,171) | | | Accretion of redeemable convertible preferred stock (related party) | (105,962) | | | (364,925) | | Net loss attributable to common stockholders, basic and diluted | $ | (1,134,306) | | | $ | (731,096) | | | | | | Weighted-average shares outstanding, basic and diluted | 328,285,861 | | | 303,631,731 | | | | | | | Net loss per share attributable to common stockholders, basic and diluted | $ | (3.46) | | | $ | (2.41) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect: | | | | | | | | | | | | | March 31, | | Excluded Securities | 2026 | | 2025 | | Private Placement Warrants to purchase common stock | 4,435,000 | | | 4,435,000 | | | Options outstanding to purchase common stock | 1,640,548 | | | 2,644,818 | | | RSUs outstanding | 16,548,056 | | | 8,652,524 | | | Employee stock purchase plan | 4,886,841 | | | 2,414,344 | | If-converted common shares from 2026 Notes | 372,950 | | | 3,673,819 | | If-converted common shares from 2030 Notes | 36,666,630 | | | — | | If-converted common shares from 2031 Notes | 46,846,313 | | | — | | If-converted common shares from Series A redeemable convertible preferred stock | 33,258,443 | | | 30,426,265 | | If-converted common shares from Series B redeemable convertible preferred stock | 19,794,423 | | | 18,108,797 | | | Total | 164,449,204 | | | 70,355,567 | |
|